Join
Live feed
·
INSIDERFilingvia Quantisnow
Kinnate Biopharma Inc. logo

Meltz Mark A returned 27,578 shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KNTE· Kinnate Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KNTE (Kinnate Biopharma Inc.) and more on Quantisnow.